MIT develops thin-film 'micro pharmacy' ( CAMBRIDGE Mass.--A new thin-film coa...)

MIT develops thin-film 'micro pharmacy'

Date:2/11/2008

CAMBRIDGE, Mass.--A new thin-film coating developed at MIT can deliver controlled drug doses to specific targets in the body following implantation, essentially serving as a micro pharmacy.

The film could eventually be used to deliver drugs for cancer, epilepsy, diabetes and other diseases. It is among the first drug-delivery coatings that can be remotely activated by applying a small electric field.

You can mete out what is needed, exactly when it's needed, in a systematic fashion, said Paula Hammond, the Bayer Professor of Chemical Engineering and senior author of a paper on the work appearing in the Feb. 11 issue of the Proceedings of the National Academy of Sciences.

The film, which is typically about 150 nanometers (billionths of a meter) thick, can be implanted in specific parts of the body.

The films are made from alternating layers of two materials: a negatively charged pigment and a positively charged drug molecule, or a neutral drug wrapped in a positively charged molecule.

The pigment, called Prussian Blue, sandwiches the drug molecules and holds them in place. (Part of the reason the researchers chose to work with Prussian Blue is that the FDA has already found it safe for use in humans.)

When an electrical potential is applied to the film, the Prussian Blue loses its negative charge, which causes the film to disintegrate, releasing the drugs. The amount of drug delivered and the timing of the dose can be precisely controlled by turning the voltage on and off.

The electrical signal can be remotely administered (for example, by a physician) using radio signals or other techniques that have already been developed for other biomedical devices.

The films can carry discrete packets of drugs that can be released separately, which could be especially beneficial for chemotherapy. The research team is now working on loading the films with different cancer drugs.

Eventually, dev
'/>"/>

Contact: Elizabeth Thomson
thomson@mit.edu
617-258-5402
Massachusetts Institute of Technology
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. Capsulated Systems, Inc. Develops Long Term Local Anesthetic
2. OHSU Cancer Institute researcher develops test for targeted therapy in acute myeloid leukemia
3. Silverchair Learning Systems Updates and Develops New Courses
4. Biomarkers predict risk for invasive breast cancer years before the tumor develops
5. UCLA doctor develops new technique to treat varicose veins
6. Corey McPherson Nash Develops Case Statement for Dana-Farber Cancer Institute Capital Campaign
7. Couples more likely to divorce if spouse develops cervical or testicular cancer
8. NeoStrata Clinical Findings Reveal Benefits of Combining Glycolic Acid Peels and Targeted Home Care With Microdermabrasion for Optimized Treatment of Photodamaged Skin
9. Dblur Concludes Licensing Deal With STMicroelectronics
10. Microsoft Dynamics CRM 4.0 Users now can include Telephony and Call Recording features by adding ConversationPRO(TM) from VoiceGate, a Division of IgeaCare Systems Inc.
11. Opportunity Internationals Micro Insurance Agency to Develop and Provide Life, Health and Crop Insurance for 21 Million Poor People

Post Your Comments:

(Date:5/22/2013)... 22, 2013 Following the success of ... franchise Fit Body Boot Camp Kincardine has announced ... Meltdown Challenge starting on June 3rd at its ... Durham Street, Kincardine, Ontario. , Fit Body Boot Camp’s ... motivate local community residents to lose a total of ...

(Date:5/22/2013)... NJ (PRWEB) May 22, 2013 ... and management solutions for social enterprise collaboration platforms, ... a consulting firm based in Chicago, Ill. The ... their products and provide best-in-class solutions for SharePoint ... improve collaboration. , AvePoint’s DocAve Software Platform ...

(Date:5/22/2013)... May 22, 2013 Poor adherence to ... not only medical complications and death (some 125,000 deaths ... non-adherence), but increased health-care costs. It’s been estimated that ... are related to poor medication adherence — a reality ... annually. , Indeed, so dire is the degree of ...

(Date:5/22/2013)... 2013 Athletic-Minded Traveler LLC, a ... released today its 2013 U.S. Business Hotel “Fit ... the company’s recommendation after ongoing research of over ... by the editorial staff. Selection criteria included ... court, etc.), in-room workout choices, healthy food offerings, ...

(Date:5/21/2013)... 22, 2013 Swimsuit season is almost here. ... ® products has begun with a 35% discount. , Cellulite ... Many women get the dreaded cellulite even if they are ... skin where they have been stored as toxic lymph and ... easy fixes, a specific program that works to dissolve the ...

Breaking Medicine News(10 mins):Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2 Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3 Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2 Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3 Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2 Health News:2013: The 10 Healthiest Business Hotels in the U.S. 2 Health News:Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale" 2

[0] Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity [0] AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration [0] Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance [0] 2013: The 10 Healthiest Business Hotels in the U.S.[0] Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale"

... to Health Care Management WASHINGTON, May 5 ... and education organization, announced today that Christine G. Leyden, ... Chief Accreditation Officer for URAC has been recognized as ... in Point magazine. Ms. Leyden will be featured ...

... Education Campaign to Share Her Weight-Loss Journey and Inspire Other ... year, actress Caitlin Van Zandt of "Guiding Light" and "The ... the United States,(1) causing her to also be one of ... at risk of heart disease.(2) Caitlin was at risk of ...

... behind on shots when parents don,t make it to ... Scheduling issues, communication problems and a lack of belief ... some of the biggest hurdles to getting parents to ... report. , Missed appointments were linked to children being ...

... Osteosarcoma is the most common and potentially most dangerous ... of 10 - 25. In "Cancer from A to Z" ... dictionary by Dr. Edward Laughlin, learn that before the 1980,s ... be an intimidating place to enter, and the terminology barrier ...

... Demonstrated in Favorable Response Rates and Hearing PreservationSUNNYVALE, ... ARAY ), a global leader in the ... data using the CyberKnife(R) Robotic Radiosurgery System was ... Association of Neurological Surgeons (AANS) Annual Meeting, May ...

... Help Her get a Good Night,s Sleep at the Samaritan ... This week, sons and daughters all over the community will ... woman in their life - Mom. Flowers, cards and ... are lacking is a good night,s sleep."The need for sleep ...

Case in Point Magazine Names URAC Senior Vice President Leader in Health Care Accreditation Video: New Survey Finds 97 Percent of Women Understand Weight Increases Heart Disease Risk - The Leading Cause of Female Death in the United States - Yet 55 Percent Remain Overweight Keeping Appointments Key to Keeping Vaccines on Track 'Cancer from A to Z': A Dictionary of Cancer-Related Terms Presentations at Leading Neurosurgery Meeting Highlight Benefits of CyberKnife Radiosurgery for the Treatment of CNS Indications What does Mom really want for Mothers Day?

(Date:5/22/2013)... FRANCISCO, Calif. , May 22, 2013 ... announced the clinical advancement of three programs in development. ... of a JAK/SYK inhibitor, R348, being developed by Rigel ... two programs are aimed at oncology targets and are ... inhibitor under development by BerGenBio AS (BerGenBio) and a ...

(Date:5/22/2013)... May 22, 2013 WomanCare Global recently ... with an extensive training initiative attended by 90 ... http://photos.prnewswire.com/prnh/20130522/DC18844 ) (Logo: http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) ... a highly effective subdermal implant composed of two ... levonorgestrel (a synthetic form of the hormone progestin). ...

(Date:5/21/2013)... 2013 NxStage Medical, Inc. (Nasdaq: NXTM ... announced that it has entered into new agreements covering ... to DaVita, the kidney care division of DaVita Healthcare Partners ... For the use of products for home hemodialysis ... has executed a second amended and restated National Service ...

Breaking Medicine Technology:Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2 Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3 Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4 WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile 2 NxStage Announces New Agreements with DaVita 2

[0] Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye [0] WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile [0] NxStage Announces New Agreements with DaVita

... /PRNewswire-USNewswire/ -- The Barbara,Ann Karmanos Cancer Institute's Philip ... oncology, presented the outcome,of one of the largest ... America and chaired an education session about the,future ... of,Clinical Oncology (ASCO) annual meeting in Chicago, IL. ...

... 2007 - First-in-human results for,IMC-A12, a monoclonal antibody ... to IGF-1R (insulin-like,growth factor type 1 receptor), were ... of Clinical Oncology in Chicago.,The IGF-IR is expressed ... transmits signals that lead to tumor cell growth ...

Cached Medicine Technology:Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 2 Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 3 Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal,Antibody IMC-A12 Presented at ASCO 2 Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal,Antibody IMC-A12 Presented at ASCO 3

Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal,Antibody IMC-A12 Presented at ASCO

The Storz Protege is an anterior segment unit only....

The Storz Premiere comes as anterior, posterior and anterior/posterior combo. The combo provides the following modes irrigation, irrigation/aspiration, vitrectomy, and illumination....

Compact ultrasonic phacoemulsification system....

... Precisionist workstation is a unique combination ... allowing infinite flexibility for modular hardware ... the demands of changing cataract surgical ... concept in ophthalmic surgical platforms providing ...

Medicine Products:

Storz Phaco Protige Storz Phaco Premiere Compact Ultrasonic Phacoemulsification System Precisionist Phacoemulsification System